# Hyperprogressive Disease in Patients With Advanced Non–Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/hyperprogressive-disease-in-patients-with-advanced-non-small-cell-lung-cancer/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Roberto Ferrara,Laura Mezquita,Matthieu Texier,J. Lahmar,Clarisse Audigier-Valette,Laurent Tessonnier,Julien Mazières,Gérard Zalcman,Solenn Brosseau,Sylvestre Le Moulec,Laura Leroy,Boris Duchemann,Corentin Lefebvre,Rémi Veillon,Virginie Westeel,Serge Koscielny,Stéphane Champiat,Charles Ferté,David Planchard,Jordi Remón,Marie‐Eve Boucher,Anas Gazzah,Julien Adam,Emilio Bria,Giampaolo Tortora,Jean‐Charles Soria,Benjamin Besse,Caroline Caramella |
| Citations | 739 |
| DOI | 10.1001/jamaoncol.2018.3676 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://jamanetwork.com/journals/jamaoncology/articlepdf/2698845/jamaoncology_ferrara_2018_oi_180067.pdf |
| OpenAlex ID | https://openalex.org/W2891266481 |
| PMID | 30193240 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Benjamin Besse](https://scholariq.org/researchers/benjamin-besse/)
- [David Planchard](https://scholariq.org/researchers/david-planchard/)
- [Julien Mazières](https://scholariq.org/researchers/julien-mazieres/)
- [Boris Duchemann](https://scholariq.org/researchers/boris-duchemann/)

## Paper journal

- [JAMA Oncology](https://scholariq.org/journals/jama-oncology/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Radiomics and Machine Learning in Medical Imaging](https://scholariq.org/topics/radiomics-and-machine-learning-in-medical-imaging/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.